Newer type 2 diabetes medications have heart and kidney disease benefits, too

Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease and cardiometabolic disease […]

Continue Reading

New abdominal aortic aneurysm genes identified, could help pinpoint those at risk

A veteran’s study identified more than a dozen genes associated with abdominal aortic aneurysm (AAA) that could be used to better identify people at risk for the often-deadly condition, according to new research published today in the American Heart Association’s flagship journal Circulation. Abdominal aortic aneurysm is a bulging or weakening of the aorta—the largest […]

Continue Reading